Anderson Daniel, Vlachostergios Panagiotis J, Simpson Lilly, Bruce Susanna Schuster, Fitzpatrick Niall, Connell Jacqueline, Christodoulis Eleftherios, Kamposioras Konstantinos
Department of Psycho-Oncology, The Christie NHS Foundation Trust, Manchester, UK.
Department of Medical Oncology, IASO Thessalias Hospital, Larissa, Greece.
Sci Rep. 2025 Mar 26;15(1):10397. doi: 10.1038/s41598-025-94538-5.
To assess for associations of known psychometric scales GAD-7, PHQ-9, pc-PTSD-5 with demographics and clinical characteristics of cancer patients as well as identify their value in screening for distress and in guiding Psycho-Oncology evaluation. This prospective feasibility study employed three psychological testing questionnaires, specifically the GAD-7, PHQ-9, and PC-PTSD-5, for the purpose of distress screening. Patients with a diagnosis of colorectal cancer who scored highly on at least one psychometric scale (defined in previous studies of non-cancer populations as a GAD-7 score of 10 or above, a PHQ-9 score of 10 or above, or a PC-PTSD-5 score of 4 or above) were offered a referral for further assessment in the Psycho-Oncology service and triaged via a semi-structured interview. The relationship between patients' demographics and clinical characteristics and scores and outcomes was evaluated using the chi-square test. Fifty-four patients (30 females) of median age 60 years (range 36-81) were evaluated in the study. Thirty-four patients (63%) scored high on GAD-7, 40 (74%) on PHQ-9, and 8 (15%) on PC-PTSD-5 scales, respectively. Twenty-nine out of the 54 patients who underwent initial assessment with the psychometric scales (53.7%) accepted to be referred to the Psycho-Oncology service and were triaged via semi-structured interview while the rest 25/54 (46.3%) patients declined further assessment. Twenty-two of the patients who were interviewed (76%) required further specialist Psycho-Oncology intervention and the rest were signposted to community services. Patients younger than 65 years of age were more likely to score high according to the GAD-7 tool (p = 0.036). White Caucasian patients tended to score higher in the PHQ-9 questionnaire compared to non-white ones (p = 0.07). Prior history of mental disorder was significantly associated with higher scores in both GAD-7 (p = 0.041) and PC-PTSD-5 tools (p = 0.016). Patients who accepted a referral for psycho-oncology intervention demonstrated statistically elevated levels of anxiety on GAD-7 (p = 0.007) and diminished levels of depression on PHQ-9 (p = 0.042) compared to those who declined the referral. A clinical pathway involving a stepwise approach of psychometric scale evaluation and semi-structured interview can appropriately identify cancer patients with distress requiring further psychological support.
评估已知心理测量量表广泛性焦虑障碍量表(GAD - 7)、患者健康问卷(PHQ - 9)、创伤后应激障碍检查表平民版(pc - PTSD - 5)与癌症患者人口统计学和临床特征之间的关联,并确定其在筛查痛苦以及指导心理肿瘤学评估中的价值。这项前瞻性可行性研究采用了三种心理测试问卷,即GAD - 7、PHQ - 9和PC - PTSD - 5,用于痛苦筛查。对至少在一种心理测量量表上得分较高(在先前非癌症人群研究中定义为GAD - 7得分10分及以上、PHQ - 9得分10分及以上或PC - PTSD - 5得分4分及以上)的结直肠癌患者,转介至心理肿瘤学服务部门进行进一步评估,并通过半结构化访谈进行分类。使用卡方检验评估患者的人口统计学和临床特征与得分及结果之间的关系。研究评估了54例患者(30例女性),中位年龄60岁(范围36 - 81岁)。分别有34例患者(63%)GAD - 7得分高,40例(74%)PHQ - 9得分高,8例(15%)PC - PTSD - 5得分高。在接受心理测量量表初始评估的54例患者中,29例(53.7%)接受转介至心理肿瘤学服务部门并通过半结构化访谈进行分类,其余25/54例(46.3%)患者拒绝进一步评估。接受访谈的22例患者(76%)需要进一步的心理肿瘤学专科干预,其余患者被指引至社区服务。根据GAD - 7工具,65岁以下的患者更有可能得分高(p = 0.036)。与非白人患者相比,白人患者在PHQ - 9问卷中的得分往往更高(p = 0.07)。精神障碍既往史与GAD - 7(p = 0.041)和PC - PTSD - 5工具(p = 0.016)得分较高均显著相关。与拒绝转介的患者相比,接受心理肿瘤学干预转介的患者在GAD - 7上的焦虑水平在统计学上升高(p = 0.007),在PHQ - 9上的抑郁水平降低(p = 0.042)。一种涉及心理测量量表评估和半结构化访谈逐步方法的临床路径可以适当地识别出有痛苦需要进一步心理支持的癌症患者。